China SXT Pharmaceuticals, Inc. (SXTC) Free cash flow 2018–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.0MFY2026 · since FY2018: $1.7M → -$4.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.0M | -70.9% |
| FY2025 | -$2.4M | — |
| FY2023 | -$141,689 | -174.6% |
| FY2022 | $189,991 | +113.1% |
| FY2021 | -$1.4M | -463.3% |
| FY2020 | $398,422 | +302.4% |
| FY2019 | -$196,825 | -111.3% |
| FY2018 | $1.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice